nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Clobetasol propionate—psoriasis	0.0703	0.129	CbGbCtD
Doxepin—CYP1A2—Methoxsalen—psoriasis	0.0369	0.068	CbGbCtD
Doxepin—CYP2D6—Hydroxyurea—psoriasis	0.0333	0.0613	CbGbCtD
Doxepin—CYP2C19—Cholecalciferol—psoriasis	0.0265	0.0488	CbGbCtD
Doxepin—CYP3A4—Calcitriol—psoriasis	0.0249	0.0458	CbGbCtD
Doxepin—CYP2C9—Cholecalciferol—psoriasis	0.022	0.0406	CbGbCtD
Doxepin—CYP2D6—Cholecalciferol—psoriasis	0.0201	0.0371	CbGbCtD
Doxepin—CYP3A4—Methoxsalen—psoriasis	0.0193	0.0356	CbGbCtD
Doxepin—ABCB1—Mycophenolate mofetil—psoriasis	0.0185	0.0342	CbGbCtD
Doxepin—CYP2C19—Prednisone—psoriasis	0.0184	0.0338	CbGbCtD
Doxepin—CYP2C19—Cyclosporine—psoriasis	0.0174	0.0321	CbGbCtD
Doxepin—ABCB1—Betamethasone—psoriasis	0.0159	0.0293	CbGbCtD
Doxepin—ABCB1—Prednisolone—psoriasis	0.0157	0.0289	CbGbCtD
Doxepin—ABCB1—Hydrocortisone—psoriasis	0.0149	0.0274	CbGbCtD
Doxepin—ABCB1—Prednisone—psoriasis	0.0148	0.0273	CbGbCtD
Doxepin—CYP2C9—Cyclosporine—psoriasis	0.0145	0.0267	CbGbCtD
Doxepin—ABCB1—Cyclosporine—psoriasis	0.0141	0.0259	CbGbCtD
Doxepin—CYP2D6—Cyclosporine—psoriasis	0.0132	0.0244	CbGbCtD
Doxepin—CYP3A4—Cholecalciferol—psoriasis	0.0128	0.0236	CbGbCtD
Doxepin—CYP2C19—Dexamethasone—psoriasis	0.0115	0.0211	CbGbCtD
Doxepin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0111	0.0205	CbGbCtD
Doxepin—CYP3A4—Triamcinolone—psoriasis	0.0111	0.0205	CbGbCtD
Doxepin—CYP2C9—Dexamethasone—psoriasis	0.00953	0.0176	CbGbCtD
Doxepin—CYP3A4—Betamethasone—psoriasis	0.00953	0.0176	CbGbCtD
Doxepin—CYP3A4—Prednisolone—psoriasis	0.0094	0.0173	CbGbCtD
Doxepin—ABCB1—Dexamethasone—psoriasis	0.00925	0.017	CbGbCtD
Doxepin—CYP3A4—Hydrocortisone—psoriasis	0.00892	0.0164	CbGbCtD
Doxepin—CYP3A4—Prednisone—psoriasis	0.00888	0.0164	CbGbCtD
Doxepin—CYP2D6—Dexamethasone—psoriasis	0.00872	0.0161	CbGbCtD
Doxepin—CYP3A4—Cyclosporine—psoriasis	0.00842	0.0155	CbGbCtD
Doxepin—ABCB1—Methotrexate—psoriasis	0.00744	0.0137	CbGbCtD
Doxepin—CYP3A4—Dexamethasone—psoriasis	0.00554	0.0102	CbGbCtD
Doxepin—Anxiety—Betamethasone—psoriasis	0.00011	0.000279	CcSEcCtD
Doxepin—Anxiety—Dexamethasone—psoriasis	0.00011	0.000279	CcSEcCtD
Doxepin—Vomiting—Mycophenolic acid—psoriasis	0.000109	0.000278	CcSEcCtD
Doxepin—Discomfort—Dexamethasone—psoriasis	0.000109	0.000276	CcSEcCtD
Doxepin—Discomfort—Betamethasone—psoriasis	0.000109	0.000276	CcSEcCtD
Doxepin—Dyspepsia—Hydrocortisone—psoriasis	0.000109	0.000276	CcSEcCtD
Doxepin—Rash—Mycophenolic acid—psoriasis	0.000108	0.000275	CcSEcCtD
Doxepin—Dermatitis—Mycophenolic acid—psoriasis	0.000108	0.000275	CcSEcCtD
Doxepin—Pain—Prednisolone—psoriasis	0.000108	0.000275	CcSEcCtD
Doxepin—Hepatitis—Methotrexate—psoriasis	0.000108	0.000275	CcSEcCtD
Doxepin—Urticaria—Mycophenolate mofetil—psoriasis	0.000108	0.000274	CcSEcCtD
Doxepin—Headache—Mycophenolic acid—psoriasis	0.000108	0.000274	CcSEcCtD
Doxepin—Decreased appetite—Hydrocortisone—psoriasis	0.000108	0.000273	CcSEcCtD
Doxepin—Pharyngitis—Methotrexate—psoriasis	0.000107	0.000273	CcSEcCtD
Doxepin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000107	0.000272	CcSEcCtD
Doxepin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000107	0.000272	CcSEcCtD
Doxepin—Urinary tract disorder—Methotrexate—psoriasis	0.000107	0.000271	CcSEcCtD
Doxepin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000107	0.000271	CcSEcCtD
Doxepin—Fatigue—Hydrocortisone—psoriasis	0.000107	0.000271	CcSEcCtD
Doxepin—Vision blurred—Prednisone—psoriasis	0.000106	0.00027	CcSEcCtD
Doxepin—Urethral disorder—Methotrexate—psoriasis	0.000106	0.000269	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000106	0.000269	CcSEcCtD
Doxepin—Pain—Hydrocortisone—psoriasis	0.000106	0.000268	CcSEcCtD
Doxepin—Oedema—Dexamethasone—psoriasis	0.000106	0.000268	CcSEcCtD
Doxepin—Oedema—Betamethasone—psoriasis	0.000106	0.000268	CcSEcCtD
Doxepin—Insomnia—Triamcinolone—psoriasis	0.000105	0.000267	CcSEcCtD
Doxepin—Infection—Dexamethasone—psoriasis	0.000105	0.000266	CcSEcCtD
Doxepin—Infection—Betamethasone—psoriasis	0.000105	0.000266	CcSEcCtD
Doxepin—Ill-defined disorder—Prednisone—psoriasis	0.000105	0.000266	CcSEcCtD
Doxepin—Paraesthesia—Triamcinolone—psoriasis	0.000105	0.000265	CcSEcCtD
Doxepin—Feeling abnormal—Prednisolone—psoriasis	0.000104	0.000265	CcSEcCtD
Doxepin—Anaemia—Prednisone—psoriasis	0.000104	0.000265	CcSEcCtD
Doxepin—Shock—Betamethasone—psoriasis	0.000104	0.000264	CcSEcCtD
Doxepin—Shock—Dexamethasone—psoriasis	0.000104	0.000264	CcSEcCtD
Doxepin—Dyspnoea—Triamcinolone—psoriasis	0.000104	0.000264	CcSEcCtD
Doxepin—Nervous system disorder—Betamethasone—psoriasis	0.000104	0.000263	CcSEcCtD
Doxepin—Nervous system disorder—Dexamethasone—psoriasis	0.000104	0.000263	CcSEcCtD
Doxepin—Agitation—Prednisone—psoriasis	0.000104	0.000263	CcSEcCtD
Doxepin—Thrombocytopenia—Dexamethasone—psoriasis	0.000103	0.000263	CcSEcCtD
Doxepin—Thrombocytopenia—Betamethasone—psoriasis	0.000103	0.000263	CcSEcCtD
Doxepin—Tachycardia—Dexamethasone—psoriasis	0.000103	0.000262	CcSEcCtD
Doxepin—Tachycardia—Betamethasone—psoriasis	0.000103	0.000262	CcSEcCtD
Doxepin—Hypersensitivity—Cyclosporine—psoriasis	0.000103	0.00026	CcSEcCtD
Doxepin—Dyspepsia—Triamcinolone—psoriasis	0.000103	0.00026	CcSEcCtD
Doxepin—Nausea—Mycophenolic acid—psoriasis	0.000102	0.000259	CcSEcCtD
Doxepin—Hyperhidrosis—Betamethasone—psoriasis	0.000102	0.000259	CcSEcCtD
Doxepin—Hyperhidrosis—Dexamethasone—psoriasis	0.000102	0.000259	CcSEcCtD
Doxepin—Feeling abnormal—Hydrocortisone—psoriasis	0.000102	0.000259	CcSEcCtD
Doxepin—Malaise—Prednisone—psoriasis	0.000102	0.000258	CcSEcCtD
Doxepin—Vertigo—Prednisone—psoriasis	0.000101	0.000257	CcSEcCtD
Doxepin—Eye disorder—Methotrexate—psoriasis	0.000101	0.000257	CcSEcCtD
Doxepin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000101	0.000257	CcSEcCtD
Doxepin—Syncope—Prednisone—psoriasis	0.000101	0.000257	CcSEcCtD
Doxepin—Tinnitus—Methotrexate—psoriasis	0.000101	0.000256	CcSEcCtD
Doxepin—Anorexia—Betamethasone—psoriasis	0.000101	0.000256	CcSEcCtD
Doxepin—Anorexia—Dexamethasone—psoriasis	0.000101	0.000256	CcSEcCtD
Doxepin—Urticaria—Prednisolone—psoriasis	0.000101	0.000255	CcSEcCtD
Doxepin—Cardiac disorder—Methotrexate—psoriasis	0.0001	0.000255	CcSEcCtD
Doxepin—Fatigue—Triamcinolone—psoriasis	0.0001	0.000255	CcSEcCtD
Doxepin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.0001	0.000254	CcSEcCtD
Doxepin—Asthenia—Cyclosporine—psoriasis	9.99e-05	0.000253	CcSEcCtD
Doxepin—Pain—Triamcinolone—psoriasis	9.96e-05	0.000253	CcSEcCtD
Doxepin—Loss of consciousness—Prednisone—psoriasis	9.91e-05	0.000252	CcSEcCtD
Doxepin—Hypotension—Betamethasone—psoriasis	9.88e-05	0.000251	CcSEcCtD
Doxepin—Hypotension—Dexamethasone—psoriasis	9.88e-05	0.000251	CcSEcCtD
Doxepin—Pruritus—Cyclosporine—psoriasis	9.85e-05	0.00025	CcSEcCtD
Doxepin—Urticaria—Hydrocortisone—psoriasis	9.83e-05	0.000249	CcSEcCtD
Doxepin—Angiopathy—Methotrexate—psoriasis	9.82e-05	0.000249	CcSEcCtD
Doxepin—Immune system disorder—Methotrexate—psoriasis	9.78e-05	0.000248	CcSEcCtD
Doxepin—Abdominal pain—Hydrocortisone—psoriasis	9.78e-05	0.000248	CcSEcCtD
Doxepin—Body temperature increased—Hydrocortisone—psoriasis	9.78e-05	0.000248	CcSEcCtD
Doxepin—Convulsion—Prednisone—psoriasis	9.77e-05	0.000248	CcSEcCtD
Doxepin—Mediastinal disorder—Methotrexate—psoriasis	9.76e-05	0.000248	CcSEcCtD
Doxepin—Asthenia—Mycophenolate mofetil—psoriasis	9.74e-05	0.000247	CcSEcCtD
Doxepin—Hypertension—Prednisone—psoriasis	9.74e-05	0.000247	CcSEcCtD
Doxepin—Chills—Methotrexate—psoriasis	9.72e-05	0.000247	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Betamethasone—psoriasis	9.63e-05	0.000244	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Dexamethasone—psoriasis	9.63e-05	0.000244	CcSEcCtD
Doxepin—Pruritus—Mycophenolate mofetil—psoriasis	9.61e-05	0.000244	CcSEcCtD
Doxepin—Arthralgia—Prednisone—psoriasis	9.6e-05	0.000244	CcSEcCtD
Doxepin—Myalgia—Prednisone—psoriasis	9.6e-05	0.000244	CcSEcCtD
Doxepin—Feeling abnormal—Triamcinolone—psoriasis	9.6e-05	0.000244	CcSEcCtD
Doxepin—Anxiety—Prednisone—psoriasis	9.57e-05	0.000243	CcSEcCtD
Doxepin—Alopecia—Methotrexate—psoriasis	9.57e-05	0.000243	CcSEcCtD
Doxepin—Insomnia—Betamethasone—psoriasis	9.56e-05	0.000243	CcSEcCtD
Doxepin—Insomnia—Dexamethasone—psoriasis	9.56e-05	0.000243	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	9.54e-05	0.000242	CcSEcCtD
Doxepin—Diarrhoea—Cyclosporine—psoriasis	9.52e-05	0.000242	CcSEcCtD
Doxepin—Paraesthesia—Dexamethasone—psoriasis	9.49e-05	0.000241	CcSEcCtD
Doxepin—Paraesthesia—Betamethasone—psoriasis	9.49e-05	0.000241	CcSEcCtD
Doxepin—Discomfort—Prednisone—psoriasis	9.49e-05	0.000241	CcSEcCtD
Doxepin—Mental disorder—Methotrexate—psoriasis	9.49e-05	0.000241	CcSEcCtD
Doxepin—Erythema—Methotrexate—psoriasis	9.43e-05	0.000239	CcSEcCtD
Doxepin—Malnutrition—Methotrexate—psoriasis	9.43e-05	0.000239	CcSEcCtD
Doxepin—Hypersensitivity—Prednisolone—psoriasis	9.33e-05	0.000237	CcSEcCtD
Doxepin—Dyspepsia—Betamethasone—psoriasis	9.3e-05	0.000236	CcSEcCtD
Doxepin—Dyspepsia—Dexamethasone—psoriasis	9.3e-05	0.000236	CcSEcCtD
Doxepin—Diarrhoea—Mycophenolate mofetil—psoriasis	9.29e-05	0.000236	CcSEcCtD
Doxepin—Urticaria—Triamcinolone—psoriasis	9.25e-05	0.000235	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—psoriasis	9.23e-05	0.000234	CcSEcCtD
Doxepin—Body temperature increased—Triamcinolone—psoriasis	9.21e-05	0.000234	CcSEcCtD
Doxepin—Dizziness—Cyclosporine—psoriasis	9.21e-05	0.000234	CcSEcCtD
Doxepin—Oedema—Prednisone—psoriasis	9.2e-05	0.000234	CcSEcCtD
Doxepin—Decreased appetite—Betamethasone—psoriasis	9.19e-05	0.000233	CcSEcCtD
Doxepin—Decreased appetite—Dexamethasone—psoriasis	9.19e-05	0.000233	CcSEcCtD
Doxepin—Infection—Prednisone—psoriasis	9.14e-05	0.000232	CcSEcCtD
Doxepin—Gastrointestinal disorder—Dexamethasone—psoriasis	9.13e-05	0.000232	CcSEcCtD
Doxepin—Gastrointestinal disorder—Betamethasone—psoriasis	9.13e-05	0.000232	CcSEcCtD
Doxepin—Back pain—Methotrexate—psoriasis	9.12e-05	0.000231	CcSEcCtD
Doxepin—Hypersensitivity—Hydrocortisone—psoriasis	9.11e-05	0.000231	CcSEcCtD
Doxepin—Fatigue—Betamethasone—psoriasis	9.11e-05	0.000231	CcSEcCtD
Doxepin—Fatigue—Dexamethasone—psoriasis	9.11e-05	0.000231	CcSEcCtD
Doxepin—Shock—Prednisone—psoriasis	9.06e-05	0.00023	CcSEcCtD
Doxepin—Pain—Betamethasone—psoriasis	9.04e-05	0.000229	CcSEcCtD
Doxepin—Pain—Dexamethasone—psoriasis	9.04e-05	0.000229	CcSEcCtD
Doxepin—Nervous system disorder—Prednisone—psoriasis	9.03e-05	0.000229	CcSEcCtD
Doxepin—Tachycardia—Prednisone—psoriasis	8.98e-05	0.000228	CcSEcCtD
Doxepin—Dizziness—Mycophenolate mofetil—psoriasis	8.98e-05	0.000228	CcSEcCtD
Doxepin—Skin disorder—Prednisone—psoriasis	8.94e-05	0.000227	CcSEcCtD
Doxepin—Hyperhidrosis—Prednisone—psoriasis	8.9e-05	0.000226	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—psoriasis	8.88e-05	0.000225	CcSEcCtD
Doxepin—Asthenia—Hydrocortisone—psoriasis	8.88e-05	0.000225	CcSEcCtD
Doxepin—Vomiting—Cyclosporine—psoriasis	8.85e-05	0.000225	CcSEcCtD
Doxepin—Rash—Cyclosporine—psoriasis	8.78e-05	0.000223	CcSEcCtD
Doxepin—Anorexia—Prednisone—psoriasis	8.77e-05	0.000223	CcSEcCtD
Doxepin—Dermatitis—Cyclosporine—psoriasis	8.77e-05	0.000222	CcSEcCtD
Doxepin—Pruritus—Hydrocortisone—psoriasis	8.75e-05	0.000222	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—psoriasis	8.75e-05	0.000222	CcSEcCtD
Doxepin—Headache—Cyclosporine—psoriasis	8.72e-05	0.000221	CcSEcCtD
Doxepin—Anaemia—Methotrexate—psoriasis	8.71e-05	0.000221	CcSEcCtD
Doxepin—Feeling abnormal—Dexamethasone—psoriasis	8.71e-05	0.000221	CcSEcCtD
Doxepin—Feeling abnormal—Betamethasone—psoriasis	8.71e-05	0.000221	CcSEcCtD
Doxepin—Gastrointestinal pain—Betamethasone—psoriasis	8.64e-05	0.000219	CcSEcCtD
Doxepin—Gastrointestinal pain—Dexamethasone—psoriasis	8.64e-05	0.000219	CcSEcCtD
Doxepin—Vomiting—Mycophenolate mofetil—psoriasis	8.63e-05	0.000219	CcSEcCtD
Doxepin—Hypersensitivity—Triamcinolone—psoriasis	8.58e-05	0.000218	CcSEcCtD
Doxepin—Rash—Mycophenolate mofetil—psoriasis	8.56e-05	0.000217	CcSEcCtD
Doxepin—Dermatitis—Mycophenolate mofetil—psoriasis	8.55e-05	0.000217	CcSEcCtD
Doxepin—Headache—Mycophenolate mofetil—psoriasis	8.51e-05	0.000216	CcSEcCtD
Doxepin—Malaise—Methotrexate—psoriasis	8.5e-05	0.000216	CcSEcCtD
Doxepin—Vertigo—Methotrexate—psoriasis	8.47e-05	0.000215	CcSEcCtD
Doxepin—Diarrhoea—Hydrocortisone—psoriasis	8.46e-05	0.000215	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—psoriasis	8.44e-05	0.000214	CcSEcCtD
Doxepin—Urticaria—Dexamethasone—psoriasis	8.4e-05	0.000213	CcSEcCtD
Doxepin—Urticaria—Betamethasone—psoriasis	8.4e-05	0.000213	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Prednisone—psoriasis	8.39e-05	0.000213	CcSEcCtD
Doxepin—Dizziness—Prednisolone—psoriasis	8.38e-05	0.000213	CcSEcCtD
Doxepin—Asthenia—Triamcinolone—psoriasis	8.36e-05	0.000212	CcSEcCtD
Doxepin—Body temperature increased—Betamethasone—psoriasis	8.36e-05	0.000212	CcSEcCtD
Doxepin—Abdominal pain—Betamethasone—psoriasis	8.36e-05	0.000212	CcSEcCtD
Doxepin—Abdominal pain—Dexamethasone—psoriasis	8.36e-05	0.000212	CcSEcCtD
Doxepin—Body temperature increased—Dexamethasone—psoriasis	8.36e-05	0.000212	CcSEcCtD
Doxepin—Insomnia—Prednisone—psoriasis	8.33e-05	0.000211	CcSEcCtD
Doxepin—Nausea—Cyclosporine—psoriasis	8.27e-05	0.00021	CcSEcCtD
Doxepin—Paraesthesia—Prednisone—psoriasis	8.27e-05	0.00021	CcSEcCtD
Doxepin—Pruritus—Triamcinolone—psoriasis	8.24e-05	0.000209	CcSEcCtD
Doxepin—Cough—Methotrexate—psoriasis	8.23e-05	0.000209	CcSEcCtD
Doxepin—Dizziness—Hydrocortisone—psoriasis	8.18e-05	0.000208	CcSEcCtD
Doxepin—Convulsion—Methotrexate—psoriasis	8.17e-05	0.000207	CcSEcCtD
Doxepin—Dyspepsia—Prednisone—psoriasis	8.1e-05	0.000206	CcSEcCtD
Doxepin—Nausea—Mycophenolate mofetil—psoriasis	8.07e-05	0.000205	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—psoriasis	8.02e-05	0.000204	CcSEcCtD
Doxepin—Chest pain—Methotrexate—psoriasis	8.02e-05	0.000204	CcSEcCtD
Doxepin—Myalgia—Methotrexate—psoriasis	8.02e-05	0.000204	CcSEcCtD
Doxepin—Decreased appetite—Prednisone—psoriasis	8e-05	0.000203	CcSEcCtD
Doxepin—Rash—Prednisolone—psoriasis	7.99e-05	0.000203	CcSEcCtD
Doxepin—Dermatitis—Prednisolone—psoriasis	7.98e-05	0.000202	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	7.97e-05	0.000202	CcSEcCtD
Doxepin—Fatigue—Prednisone—psoriasis	7.94e-05	0.000201	CcSEcCtD
Doxepin—Headache—Prednisolone—psoriasis	7.94e-05	0.000201	CcSEcCtD
Doxepin—Discomfort—Methotrexate—psoriasis	7.93e-05	0.000201	CcSEcCtD
Doxepin—Constipation—Prednisone—psoriasis	7.87e-05	0.0002	CcSEcCtD
Doxepin—Vomiting—Hydrocortisone—psoriasis	7.87e-05	0.0002	CcSEcCtD
Doxepin—Rash—Hydrocortisone—psoriasis	7.8e-05	0.000198	CcSEcCtD
Doxepin—Dermatitis—Hydrocortisone—psoriasis	7.79e-05	0.000198	CcSEcCtD
Doxepin—Confusional state—Methotrexate—psoriasis	7.76e-05	0.000197	CcSEcCtD
Doxepin—Headache—Hydrocortisone—psoriasis	7.75e-05	0.000197	CcSEcCtD
Doxepin—Dizziness—Triamcinolone—psoriasis	7.7e-05	0.000195	CcSEcCtD
Doxepin—Infection—Methotrexate—psoriasis	7.64e-05	0.000194	CcSEcCtD
Doxepin—Feeling abnormal—Prednisone—psoriasis	7.59e-05	0.000192	CcSEcCtD
Doxepin—Asthenia—Betamethasone—psoriasis	7.58e-05	0.000192	CcSEcCtD
Doxepin—Asthenia—Dexamethasone—psoriasis	7.58e-05	0.000192	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—psoriasis	7.54e-05	0.000191	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—psoriasis	7.53e-05	0.000191	CcSEcCtD
Doxepin—Gastrointestinal pain—Prednisone—psoriasis	7.53e-05	0.000191	CcSEcCtD
Doxepin—Nausea—Prednisolone—psoriasis	7.52e-05	0.000191	CcSEcCtD
Doxepin—Pruritus—Dexamethasone—psoriasis	7.48e-05	0.00019	CcSEcCtD
Doxepin—Pruritus—Betamethasone—psoriasis	7.48e-05	0.00019	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—psoriasis	7.47e-05	0.00019	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—psoriasis	7.44e-05	0.000189	CcSEcCtD
Doxepin—Vomiting—Triamcinolone—psoriasis	7.41e-05	0.000188	CcSEcCtD
Doxepin—Nausea—Hydrocortisone—psoriasis	7.35e-05	0.000186	CcSEcCtD
Doxepin—Rash—Triamcinolone—psoriasis	7.34e-05	0.000186	CcSEcCtD
Doxepin—Dermatitis—Triamcinolone—psoriasis	7.34e-05	0.000186	CcSEcCtD
Doxepin—Anorexia—Methotrexate—psoriasis	7.33e-05	0.000186	CcSEcCtD
Doxepin—Urticaria—Prednisone—psoriasis	7.31e-05	0.000186	CcSEcCtD
Doxepin—Headache—Triamcinolone—psoriasis	7.3e-05	0.000185	CcSEcCtD
Doxepin—Body temperature increased—Prednisone—psoriasis	7.28e-05	0.000185	CcSEcCtD
Doxepin—Abdominal pain—Prednisone—psoriasis	7.28e-05	0.000185	CcSEcCtD
Doxepin—Diarrhoea—Betamethasone—psoriasis	7.23e-05	0.000183	CcSEcCtD
Doxepin—Diarrhoea—Dexamethasone—psoriasis	7.23e-05	0.000183	CcSEcCtD
Doxepin—Hypotension—Methotrexate—psoriasis	7.19e-05	0.000182	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—psoriasis	7.01e-05	0.000178	CcSEcCtD
Doxepin—Dizziness—Dexamethasone—psoriasis	6.99e-05	0.000177	CcSEcCtD
Doxepin—Dizziness—Betamethasone—psoriasis	6.99e-05	0.000177	CcSEcCtD
Doxepin—Insomnia—Methotrexate—psoriasis	6.96e-05	0.000177	CcSEcCtD
Doxepin—Nausea—Triamcinolone—psoriasis	6.92e-05	0.000176	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—psoriasis	6.91e-05	0.000175	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—psoriasis	6.86e-05	0.000174	CcSEcCtD
Doxepin—Somnolence—Methotrexate—psoriasis	6.84e-05	0.000174	CcSEcCtD
Doxepin—Hypersensitivity—Prednisone—psoriasis	6.78e-05	0.000172	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—psoriasis	6.77e-05	0.000172	CcSEcCtD
Doxepin—Vomiting—Betamethasone—psoriasis	6.72e-05	0.000171	CcSEcCtD
Doxepin—Vomiting—Dexamethasone—psoriasis	6.72e-05	0.000171	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—psoriasis	6.69e-05	0.00017	CcSEcCtD
Doxepin—Rash—Dexamethasone—psoriasis	6.66e-05	0.000169	CcSEcCtD
Doxepin—Rash—Betamethasone—psoriasis	6.66e-05	0.000169	CcSEcCtD
Doxepin—Dermatitis—Dexamethasone—psoriasis	6.66e-05	0.000169	CcSEcCtD
Doxepin—Dermatitis—Betamethasone—psoriasis	6.66e-05	0.000169	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—psoriasis	6.64e-05	0.000169	CcSEcCtD
Doxepin—Fatigue—Methotrexate—psoriasis	6.63e-05	0.000168	CcSEcCtD
Doxepin—Headache—Betamethasone—psoriasis	6.62e-05	0.000168	CcSEcCtD
Doxepin—Headache—Dexamethasone—psoriasis	6.62e-05	0.000168	CcSEcCtD
Doxepin—Asthenia—Prednisone—psoriasis	6.6e-05	0.000168	CcSEcCtD
Doxepin—Pain—Methotrexate—psoriasis	6.58e-05	0.000167	CcSEcCtD
Doxepin—Pruritus—Prednisone—psoriasis	6.51e-05	0.000165	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—psoriasis	6.34e-05	0.000161	CcSEcCtD
Doxepin—Diarrhoea—Prednisone—psoriasis	6.3e-05	0.00016	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—psoriasis	6.29e-05	0.00016	CcSEcCtD
Doxepin—Nausea—Dexamethasone—psoriasis	6.28e-05	0.000159	CcSEcCtD
Doxepin—Nausea—Betamethasone—psoriasis	6.28e-05	0.000159	CcSEcCtD
Doxepin—Urticaria—Methotrexate—psoriasis	6.11e-05	0.000155	CcSEcCtD
Doxepin—Dizziness—Prednisone—psoriasis	6.09e-05	0.000154	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—psoriasis	6.08e-05	0.000154	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—psoriasis	6.08e-05	0.000154	CcSEcCtD
Doxepin—Vomiting—Prednisone—psoriasis	5.85e-05	0.000148	CcSEcCtD
Doxepin—Rash—Prednisone—psoriasis	5.8e-05	0.000147	CcSEcCtD
Doxepin—Dermatitis—Prednisone—psoriasis	5.8e-05	0.000147	CcSEcCtD
Doxepin—Headache—Prednisone—psoriasis	5.77e-05	0.000146	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—psoriasis	5.67e-05	0.000144	CcSEcCtD
Doxepin—Asthenia—Methotrexate—psoriasis	5.52e-05	0.00014	CcSEcCtD
Doxepin—Nausea—Prednisone—psoriasis	5.47e-05	0.000139	CcSEcCtD
Doxepin—Pruritus—Methotrexate—psoriasis	5.44e-05	0.000138	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—psoriasis	5.26e-05	0.000134	CcSEcCtD
Doxepin—Dizziness—Methotrexate—psoriasis	5.09e-05	0.000129	CcSEcCtD
Doxepin—Vomiting—Methotrexate—psoriasis	4.89e-05	0.000124	CcSEcCtD
Doxepin—Rash—Methotrexate—psoriasis	4.85e-05	0.000123	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—psoriasis	4.85e-05	0.000123	CcSEcCtD
Doxepin—Headache—Methotrexate—psoriasis	4.82e-05	0.000122	CcSEcCtD
Doxepin—Nausea—Methotrexate—psoriasis	4.57e-05	0.000116	CcSEcCtD
Doxepin—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.07e-05	0.00017	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SOCS1—psoriasis	1.07e-05	0.00017	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	1.07e-05	0.000169	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—CXCL8—psoriasis	1.06e-05	0.000169	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	1.05e-05	0.000167	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.05e-05	0.000167	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—NFKB1—psoriasis	1.05e-05	0.000167	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—LEP—psoriasis	1.04e-05	0.000165	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—APOE—psoriasis	1.04e-05	0.000165	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TYK2—psoriasis	1.03e-05	0.000164	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—APOE—psoriasis	1.03e-05	0.000163	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—TYK2—psoriasis	1.02e-05	0.000162	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.02e-05	0.000162	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PPARG—psoriasis	1.01e-05	0.00016	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—LEP—psoriasis	1e-05	0.000159	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—APOE—psoriasis	1e-05	0.000159	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—APOE—psoriasis	9.98e-06	0.000158	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—LEP—psoriasis	9.98e-06	0.000158	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—CXCL8—psoriasis	9.91e-06	0.000157	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—CXCL8—psoriasis	9.77e-06	0.000155	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TYK2—psoriasis	9.76e-06	0.000155	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—CXCL8—psoriasis	9.75e-06	0.000155	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—CXCL8—psoriasis	9.73e-06	0.000154	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—LEP—psoriasis	9.71e-06	0.000154	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—APOE—psoriasis	9.71e-06	0.000154	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—CXCL8—psoriasis	9.7e-06	0.000154	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NFKBIA—psoriasis	9.69e-06	0.000154	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—CXCL8—psoriasis	9.67e-06	0.000153	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—CXCL8—psoriasis	9.58e-06	0.000152	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—LEP—psoriasis	9.56e-06	0.000152	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—APOE—psoriasis	9.56e-06	0.000152	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	9.55e-06	0.000152	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—VEGFA—psoriasis	9.54e-06	0.000151	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—TP53—psoriasis	9.49e-06	0.000151	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—STAT3—psoriasis	9.45e-06	0.00015	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TYK2—psoriasis	9.45e-06	0.00015	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—APOE—psoriasis	9.43e-06	0.00015	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NFKBIA—psoriasis	9.35e-06	0.000148	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TYK2—psoriasis	9.35e-06	0.000148	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NFKBIA—psoriasis	9.3e-06	0.000148	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—TP53—psoriasis	9.3e-06	0.000148	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NFKBIA—psoriasis	9.05e-06	0.000144	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CXCL8—psoriasis	9.01e-06	0.000143	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PPARG—psoriasis	8.96e-06	0.000142	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	8.91e-06	0.000141	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—CXCL8—psoriasis	8.87e-06	0.000141	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—APOE—psoriasis	8.81e-06	0.00014	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—LEP—psoriasis	8.81e-06	0.00014	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TYK2—psoriasis	8.79e-06	0.000139	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—APOE—psoriasis	8.67e-06	0.000138	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—LEP—psoriasis	8.67e-06	0.000138	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—LEP—psoriasis	8.65e-06	0.000137	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—APOE—psoriasis	8.65e-06	0.000137	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—APOE—psoriasis	8.62e-06	0.000137	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—LEP—psoriasis	8.62e-06	0.000137	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CAT—psoriasis	8.6e-06	0.000136	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—LEP—psoriasis	8.6e-06	0.000136	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—APOE—psoriasis	8.6e-06	0.000136	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—IL6—psoriasis	8.57e-06	0.000136	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—LEP—psoriasis	8.51e-06	0.000135	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—APOE—psoriasis	8.51e-06	0.000135	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—IL6—psoriasis	8.51e-06	0.000135	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CXCL8—psoriasis	8.5e-06	0.000135	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—LEP—psoriasis	8.49e-06	0.000135	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—APOE—psoriasis	8.49e-06	0.000135	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CARM1—psoriasis	8.41e-06	0.000133	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CAT—psoriasis	8.4e-06	0.000133	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—JUN—psoriasis	8.38e-06	0.000133	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CXCL8—psoriasis	8.22e-06	0.00013	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PPARG—psoriasis	8.22e-06	0.00013	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NFKBIA—psoriasis	8.21e-06	0.00013	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CXCL8—psoriasis	8.14e-06	0.000129	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL6—psoriasis	8.08e-06	0.000128	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NFKBIA—psoriasis	8.08e-06	0.000128	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—NFKB1—psoriasis	8.06e-06	0.000128	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NFKBIA—psoriasis	8.06e-06	0.000128	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NFKBIA—psoriasis	8.04e-06	0.000127	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NFKBIA—psoriasis	8.01e-06	0.000127	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TYK2—psoriasis	7.94e-06	0.000126	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NFKBIA—psoriasis	7.93e-06	0.000126	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CAT—psoriasis	7.91e-06	0.000126	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	7.91e-06	0.000126	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—JUN—psoriasis	7.9e-06	0.000125	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—APOE—psoriasis	7.89e-06	0.000125	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—LEP—psoriasis	7.89e-06	0.000125	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CAT—psoriasis	7.84e-06	0.000124	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL6—psoriasis	7.82e-06	0.000124	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL6—psoriasis	7.74e-06	0.000123	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TYK2—psoriasis	7.66e-06	0.000122	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CXCL8—psoriasis	7.65e-06	0.000121	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—JUN—psoriasis	7.65e-06	0.000121	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TYK2—psoriasis	7.62e-06	0.000121	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—NFKB1—psoriasis	7.61e-06	0.000121	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—JUN—psoriasis	7.57e-06	0.00012	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TYK2—psoriasis	7.41e-06	0.000118	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—NFKB1—psoriasis	7.36e-06	0.000117	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NFKBIA—psoriasis	7.35e-06	0.000117	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—VEGFA—psoriasis	7.32e-06	0.000116	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TYK2—psoriasis	7.3e-06	0.000116	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—NFKB1—psoriasis	7.28e-06	0.000116	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—psoriasis	7.28e-06	0.000115	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—STAT3—psoriasis	7.25e-06	0.000115	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—TP53—psoriasis	7.21e-06	0.000114	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—JUN—psoriasis	7.11e-06	0.000113	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CXCL8—psoriasis	6.91e-06	0.00011	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—psoriasis	6.9e-06	0.00011	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—NFKB1—psoriasis	6.85e-06	0.000109	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—STAT3—psoriasis	6.84e-06	0.000108	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TYK2—psoriasis	6.73e-06	0.000107	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CAT—psoriasis	6.7e-06	0.000106	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—psoriasis	6.68e-06	0.000106	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—psoriasis	6.68e-06	0.000106	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CXCL8—psoriasis	6.67e-06	0.000106	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CXCL8—psoriasis	6.64e-06	0.000105	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TYK2—psoriasis	6.62e-06	0.000105	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—STAT3—psoriasis	6.61e-06	0.000105	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—psoriasis	6.61e-06	0.000105	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TYK2—psoriasis	6.6e-06	0.000105	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—psoriasis	6.6e-06	0.000105	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TYK2—psoriasis	6.58e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—psoriasis	6.57e-06	0.000104	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TYK2—psoriasis	6.56e-06	0.000104	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—STAT3—psoriasis	6.55e-06	0.000104	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—psoriasis	6.52e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TYK2—psoriasis	6.5e-06	0.000103	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TYK2—psoriasis	6.48e-06	0.000103	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CXCL8—psoriasis	6.45e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—JUN—psoriasis	6.42e-06	0.000102	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CXCL8—psoriasis	6.35e-06	0.000101	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—psoriasis	6.34e-06	0.000101	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—psoriasis	6.31e-06	0.0001	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—psoriasis	6.22e-06	9.86e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—JUN—psoriasis	6.2e-06	9.84e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NFKB1—psoriasis	6.18e-06	9.81e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—JUN—psoriasis	6.17e-06	9.79e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—STAT3—psoriasis	6.15e-06	9.76e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—psoriasis	6.15e-06	9.75e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—psoriasis	6.14e-06	9.74e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—psoriasis	6.09e-06	9.67e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—psoriasis	6.04e-06	9.58e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TYK2—psoriasis	6.02e-06	9.55e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—JUN—psoriasis	6e-06	9.52e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NFKB1—psoriasis	5.97e-06	9.47e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NFKB1—psoriasis	5.94e-06	9.42e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—JUN—psoriasis	5.91e-06	9.37e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CXCL8—psoriasis	5.86e-06	9.29e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—psoriasis	5.82e-06	9.24e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NFKB1—psoriasis	5.78e-06	9.16e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CXCL8—psoriasis	5.76e-06	9.14e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CXCL8—psoriasis	5.75e-06	9.12e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CXCL8—psoriasis	5.73e-06	9.09e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CXCL8—psoriasis	5.71e-06	9.06e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NFKB1—psoriasis	5.68e-06	9.02e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—psoriasis	5.68e-06	9.01e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CXCL8—psoriasis	5.66e-06	8.97e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CXCL8—psoriasis	5.64e-06	8.95e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—psoriasis	5.61e-06	8.9e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—psoriasis	5.57e-06	8.83e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—STAT3—psoriasis	5.56e-06	8.81e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—psoriasis	5.53e-06	8.77e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—psoriasis	5.48e-06	8.69e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—psoriasis	5.47e-06	8.67e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—psoriasis	5.45e-06	8.65e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—JUN—psoriasis	5.44e-06	8.64e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—psoriasis	5.43e-06	8.62e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—psoriasis	5.42e-06	8.59e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.39e-06	8.55e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—psoriasis	5.38e-06	8.53e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.36e-06	8.51e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—STAT3—psoriasis	5.36e-06	8.51e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—JUN—psoriasis	5.36e-06	8.5e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—psoriasis	5.35e-06	8.49e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—JUN—psoriasis	5.35e-06	8.48e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—STAT3—psoriasis	5.34e-06	8.47e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—JUN—psoriasis	5.33e-06	8.45e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—JUN—psoriasis	5.31e-06	8.43e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—psoriasis	5.31e-06	8.42e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—JUN—psoriasis	5.26e-06	8.34e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—JUN—psoriasis	5.25e-06	8.32e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CXCL8—psoriasis	5.24e-06	8.32e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—psoriasis	5.24e-06	8.32e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NFKB1—psoriasis	5.24e-06	8.31e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—psoriasis	5.22e-06	8.27e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—psoriasis	5.21e-06	8.26e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—STAT3—psoriasis	5.19e-06	8.23e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAT—psoriasis	5.17e-06	8.21e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—psoriasis	5.16e-06	8.18e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.16e-06	8.18e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NFKB1—psoriasis	5.15e-06	8.16e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NFKB1—psoriasis	5.13e-06	8.14e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NFKB1—psoriasis	5.11e-06	8.11e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—STAT3—psoriasis	5.11e-06	8.1e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NFKB1—psoriasis	5.06e-06	8.03e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—psoriasis	5.06e-06	8.03e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NFKB1—psoriasis	5.05e-06	8.01e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—psoriasis	5.05e-06	8.01e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—psoriasis	5e-06	7.92e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—psoriasis	4.98e-06	7.91e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JUN—psoriasis	4.87e-06	7.73e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—psoriasis	4.77e-06	7.57e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—psoriasis	4.76e-06	7.55e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—psoriasis	4.71e-06	7.47e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—psoriasis	4.7e-06	7.45e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NFKB1—psoriasis	4.69e-06	7.44e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—psoriasis	4.68e-06	7.42e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—psoriasis	4.67e-06	7.41e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—psoriasis	4.65e-06	7.38e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—psoriasis	4.64e-06	7.36e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—psoriasis	4.63e-06	7.35e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—psoriasis	4.62e-06	7.34e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—psoriasis	4.62e-06	7.33e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—psoriasis	4.61e-06	7.31e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—psoriasis	4.59e-06	7.29e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—psoriasis	4.59e-06	7.29e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—psoriasis	4.58e-06	7.27e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—psoriasis	4.57e-06	7.25e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—psoriasis	4.55e-06	7.22e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—psoriasis	4.54e-06	7.2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—psoriasis	4.54e-06	7.2e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—psoriasis	4.3e-06	6.82e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—psoriasis	4.26e-06	6.75e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—psoriasis	4.24e-06	6.73e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—psoriasis	4.22e-06	6.69e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—psoriasis	4.09e-06	6.49e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—psoriasis	4.07e-06	6.46e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—psoriasis	4.02e-06	6.38e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—psoriasis	3.96e-06	6.28e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—psoriasis	3.9e-06	6.18e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—psoriasis	3.88e-06	6.16e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—psoriasis	3.75e-06	5.94e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—psoriasis	3.73e-06	5.91e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—psoriasis	3.63e-06	5.75e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—psoriasis	3.59e-06	5.7e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—psoriasis	3.57e-06	5.66e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—psoriasis	3.54e-06	5.61e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—psoriasis	3.53e-06	5.6e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—psoriasis	3.52e-06	5.58e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—psoriasis	3.51e-06	5.56e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—psoriasis	3.5e-06	5.55e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—psoriasis	3.47e-06	5.51e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—psoriasis	3.46e-06	5.49e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—psoriasis	3.29e-06	5.22e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—psoriasis	3.24e-06	5.13e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—psoriasis	3.23e-06	5.12e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—psoriasis	3.22e-06	5.11e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—psoriasis	3.22e-06	5.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—psoriasis	3.21e-06	5.09e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—psoriasis	3.18e-06	5.04e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—psoriasis	3.17e-06	5.03e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—psoriasis	2.94e-06	4.67e-05	CbGpPWpGaD
